{"transactions":[{"id":1569354,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":92893,"kind":"person","name":"Tada Hiroomi","position":1,"cik":"0001880593","reported_name":"Tada Hiroomi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-03-19T23:58:15.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":1968,"price":6.579,"value":12947.472,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":86435,"source":{"system":"sec-edgar","filing":"0000950170-24-033845","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024033845/ownership.xml","form_type":"4"}},{"id":1777553,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":92893,"kind":"person","name":"Tada Hiroomi","position":1,"cik":"0001880593","reported_name":"Tada Hiroomi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-09-19T23:37:49.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":1337,"price":6.579,"value":8796.123,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":84467,"source":{"system":"sec-edgar","filing":"0001209191-23-050094","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123050094/doc4.xml","form_type":"4"}},{"id":1819382,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":92893,"kind":"person","name":"Tada Hiroomi","position":1,"cik":"0001880593","reported_name":"Tada Hiroomi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-01T21:41:09.000Z","date":"2023-07-28","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following July 28, 2023, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":115000,"derivative":{"exercise_price":14.35,"expiration_date":"2033-07-27","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001209191-23-044047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123044047/doc4.xml","form_type":"4"}},{"id":1947462,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":92893,"kind":"person","name":"Tada Hiroomi","position":1,"cik":"0001880593","reported_name":"Tada Hiroomi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-17T21:27:33.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":1893,"price":6.579,"value":12454.047,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":83130,"source":{"system":"sec-edgar","filing":"0001209191-23-019791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123019791/doc4.xml","form_type":"4"}},{"id":2155961,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":92893,"kind":"person","name":"Tada Hiroomi","position":1,"cik":"0001880593","reported_name":"Tada Hiroomi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-09-19T22:20:07.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":612,"price":7.6585,"value":4687.002,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":81237,"source":{"system":"sec-edgar","filing":"0001209191-22-050612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919122050612/doc4.xml","form_type":"4"}},{"id":2163255,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":92893,"kind":"person","name":"Tada Hiroomi","position":1,"cik":"0001880593","reported_name":"Tada Hiroomi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-08T21:52:25.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":110000,"derivative":{"exercise_price":7.14,"expiration_date":"2032-09-05","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001209191-22-049218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919122049218/doc4.xml","form_type":"4"}},{"id":2163254,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":92893,"kind":"person","name":"Tada Hiroomi","position":1,"cik":"0001880593","reported_name":"Tada Hiroomi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-09-08T21:52:25.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":2703,"price":8.5255,"value":23044.4265,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":80625,"source":{"system":"sec-edgar","filing":"0001209191-22-049218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919122049218/doc4.xml","form_type":"4"}},{"id":2524774,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":92893,"kind":"person","name":"Tada Hiroomi","position":1,"cik":"0001880593","reported_name":"Tada Hiroomi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-04T23:52:54.000Z","date":"2021-11-02","kind":"grant","acquired":true,"shares":7964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests based on achievement of a performance objective."}],"balance_after":7964,"derivative":{"exercise_price":24.15,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":7964},"source":{"system":"sec-edgar","filing":"0001209191-21-063019","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919121063019/doc4.xml","form_type":"4"}},{"id":2524773,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":92893,"kind":"person","name":"Tada Hiroomi","position":1,"cik":"0001880593","reported_name":"Tada Hiroomi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-04T23:52:54.000Z","date":"2021-11-02","kind":"grant","acquired":true,"shares":7964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests based on achievement of a performance objective."}],"balance_after":7964,"derivative":{"exercise_price":24.15,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":7964},"source":{"system":"sec-edgar","filing":"0001209191-21-063019","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919121063019/doc4.xml","form_type":"4"}},{"id":2524772,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":92893,"kind":"person","name":"Tada Hiroomi","position":1,"cik":"0001880593","reported_name":"Tada Hiroomi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-04T23:52:54.000Z","date":"2021-11-02","kind":"grant","acquired":true,"shares":83626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following November 2, 2021, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":83626,"derivative":{"exercise_price":24.15,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":83626},"source":{"system":"sec-edgar","filing":"0001209191-21-063019","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919121063019/doc4.xml","form_type":"4"}}]}